Boston Partners trimmed its holdings in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report) by 46.9% in the third quarter, according to its most recent filing with the SEC. The firm owned 522,783 shares of the company’s stock after selling 461,085 shares during the period. Boston Partners owned approximately 0.83% of Guardian Pharmacy Services worth $21,357,000 as of its most recent filing with the SEC.
A number of other hedge funds have also made changes to their positions in GRDN. Nisa Investment Advisors LLC boosted its stake in Guardian Pharmacy Services by 53.5% during the 3rd quarter. Nisa Investment Advisors LLC now owns 1,050 shares of the company’s stock worth $43,000 after acquiring an additional 366 shares during the last quarter. State of Alaska Department of Revenue raised its stake in Guardian Pharmacy Services by 105.9% in the 3rd quarter. State of Alaska Department of Revenue now owns 2,390 shares of the company’s stock valued at $97,000 after acquiring an additional 1,229 shares during the period. Voya Investment Management LLC bought a new position in Guardian Pharmacy Services in the 3rd quarter valued at about $238,000. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of Guardian Pharmacy Services in the second quarter valued at about $335,000. Finally, Arizona State Retirement System grew its position in shares of Guardian Pharmacy Services by 53.0% during the 2nd quarter. Arizona State Retirement System now owns 8,393 shares of the company’s stock worth $351,000 after purchasing an additional 2,907 shares in the last quarter.
Wall Street Analyst Weigh In
GRDN has been the topic of a number of research analyst reports. Oppenheimer raised their price target on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a research note on Friday, August 7th. Weiss Ratings raised Guardian Pharmacy Services from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, November 9th. KeyCorp began coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, September 22nd. They set an “overweight” rating and a $52.00 price target on the stock. Truist Financial lifted their price objective on shares of Guardian Pharmacy Services from $47.00 to $51.00 and gave the company a “buy” rating in a research note on Monday, September 21st. Finally, Wall Street Zen raised Guardian Pharmacy Services from a “hold” rating to a “buy” rating in a research note on Saturday, November 14th. Nine investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, Guardian Pharmacy Services currently has an average rating of “Moderate Buy” and an average target price of $45.57.
Guardian Pharmacy Services Stock Performance
NYSE:GRDN opened at $47.09 on Friday. The firm has a market capitalization of $2.98 billion, a price-to-earnings ratio of 40.25, a P/E/G ratio of 2.21 and a beta of 0.06. Guardian Pharmacy Services, Inc. has a 52-week low of $26.34 and a 52-week high of $50.85. The stock has a fifty day moving average of $43.03 and a 200 day moving average of $39.21.
Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.02. Guardian Pharmacy Services had a net margin of 5.13% and a return on equity of 30.29%. The firm had revenue of $371.07 million for the quarter, compared to analysts’ expectations of $365.76 million. Equities analysts forecast that Guardian Pharmacy Services, Inc. will post 1.23 earnings per share for the current fiscal year.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc. provides pharmacy services to people living in long-term care and residential care settings. Its customers include assisted living and skilled nursing communities, behavioral health facilities, and other group-living providers. The company supplies prescription medications and offers medication packaging, delivery, consulting, and clinical support. Its services are designed to help care providers manage residents’ medication needs and support continuity of care. Founded in 2004, Guardian operates a network of pharmacies serving communities across the United States.
Recommended Stories
- Five stocks we like better than Guardian Pharmacy Services
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
